Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.


This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Year of publication 2022
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology


You are running an old browser version. We recommend updating your browser to its latest version.

More info